Osiris Therapeutics Inc

Find Ratings Reports
OSIR : NASDAQ : Health Care
$5.02 -0.03 | -0.59%
Today's Range: 4.97 - 5.20
Avg. Daily Volume: 85,600
08/26/16 - 1:34 PM ET

Financial Analysis


OSIRIS THERAPEUTICS INC's gross profit margin for the third quarter of its fiscal year 2015 has significantly decreased when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. OSIRIS THERAPEUTICS INC is extremely liquid. Currently, the Quick Ratio is 4.50 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.

During the same period, stockholders' equity ("net worth") has remained virtually unchanged only decreasing by 2.76% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q3 FY15 Q3 FY14
Net Sales ($mil)25.3317.2
EBITDA ($mil)0.611.46
EBIT ($mil)0.311.22
Net Income ($mil)-0.660.65


Balance Sheet Q3 FY15 Q3 FY14
Cash & Equiv. ($mil)43.3458.36
Total Assets ($mil)101.0291.71
Total Debt ($mil)0.050.05
Equity ($mil)79.8482.12


Profitability Q3 FY15 Q3 FY14
Gross Profit Margin2.428.5
EBITDA Margin2.418.5
Operating Margin1.227.09
Sales Turnover0.860.53
Return on Assets1.4251.46
Return on Equity2.130.18
Debt Q3 FY15 Q3 FY14
Current Ratio5.439.61
Debt/Capital0.00.0
Interest Expense0.00.0
Interest Coverage0.00.0


Share Data Q3 FY15 Q3 FY14
Shares outstanding (mil)34.4534.32
Div / share0.00.0
EPS-0.020.02
Book value / share2.322.39
Institutional Own % n/a n/a
Avg Daily Volume90593.0226263.0

Valuation


SELL. OSIRIS THERAPEUTICS INC's P/E ratio indicates a significant premium compared to an average of 43.43 for the Biotechnology industry and a significant premium compared to the S&P 500 average of 25.30. To use another comparison, its price-to-book ratio of 2.26 indicates a discount versus the S&P 500 average of 2.83 and a significant discount versus the industry average of 10.44. The price-to-sales ratio is above the S&P 500 average, but well below the industry average.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
OSIR 104.80 Peers 43.43   OSIR 83.03 Peers 21.06

Premium. A higher P/E ratio than its peers can signify a more expensive stock or higher growth expectations.

OSIR is trading at a significant premium to its peers.

 

Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.

OSIR is trading at a significant premium to its peers.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
OSIR 41.92 Peers 29.93   OSIR NM Peers 0.49

Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.

OSIR is trading at a significant premium to its peers.

 

Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

OSIR's negative PEG ratio makes this valuation measure meaningless.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
OSIR 2.26 Peers 10.44   OSIR NA Peers 0.31

Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

OSIR is trading at a significant discount to its peers.

 

Neutral. Higher earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

The growth rate for OSIR is not available.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
OSIR 2.08 Peers 555.79   OSIR 78.07 Peers 52.64

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

OSIR is trading at a significant discount to its industry on this measurement.

 

Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.

OSIR has a sales growth rate that significantly exceeds its peers.

 

 

Latest Stock Upgrades/Downgrades